Amoebicidal or amoebostatic influence of disinfectants used in health facilities and laboratories on corneal strains of Acanthamoeba

• Autorzy: Baltaza W. , Padzik M. , Szaflik J.P. , Dybicz M. , Hendiger E. , Chomicz L.
• Języki publikacji: EN

Abstrakty

EN

Different Acanthamoeba species are amphizoic organisms distributed in wide range of habitats in natural and man-made environments; they are also detected on surfaces of equipment and accessories in health facilities. Some strains of the amoebae are causative agents of the vision-threatening human disease Acanthamoeba keratitis, mainly reported in contact lens wearers. An exceptional high resistance of Acanthamoeba trophozoites and particularly cysts to chemicals, disinfectants and drugs is believed as influencing difficulty resulting in unsuccessful therapeutic management. As Acanthamoeba keratitis is the serious medical problem worldwide, different chemicals with possible activity against environmental and clinical Acanthamoeba strains are tested. In our study, selected disinfectants used in health care settings and laboratories were tested and their efficacy against the corneal strains Acanthamoeba castellanii and A. polyphaga , and environmental A. castellanii Neff strain was assessed. Comparative assessment of results of the assays show that, apart from amoebistatic effects, the disinfectants indicated expected cysticidal efficacy.

• Wydawca: -
• Czasopismo: Annals of Parasitology
• Rocznik: 2017
• Tom: 63
• Numer: 3
• Opis fizyczny: p.167-172,ref.

Twórcy

autor

Baltaza W.

• Department of Medical Biology, Medical University of Warsaw, Nowogrodzka 73, 02-018 Warsaw, Poland
• Department of Disaster Medicine, Medical University of Warsaw, Zwirki and Wigury 81, 02-091 Warsaw, Poland

autor

Padzik M.

• Department of Medical Biology, Medical University of Warsaw, Nowogrodzka 73, 02-018 Warsaw, Poland

autor

Szaflik J.P.

• Department of Ophthalmology, SPKSO Ophthalmic Hospital, Medical University of Warsaw, Sierakowskiego 13, 03-709 Warsaw, Poland

autor

Dybicz M.

• Department of Ophthalmology, SPKSO Ophthalmic Hospital, Medical University of Warsaw, Sierakowskiego 13, 03-709 Warsaw, Poland

autor

Hendiger E.

• Department of Medical Biology, Medical University of Warsaw, Nowogrodzka 73, 02-018 Warsaw, Poland
• Department of Medical Biology, Medical University of Warsaw, University’s Scientific Circle, Warsaw, Poland

autor

Chomicz L.

• Department of Medical Biology, Medical University of Warsaw, Nowogrodzka 73, 02-018 Warsaw, Poland

Bibliografia

• [1] Martinez A.J., Visvesvara G.S. 1997. Free-living, amphizoic and opportunistic amebas. Brain Pathology 7: 583-598.
• [2] Marciano-Cabral F., Cabral G. 2003. Acanthamoeba spp. as agents of disease in humans. Clinical Microbiology Reviews 16: 273-307.
• [3] Schuster F.L., Visvesvara G.S. 2004. Free-living amoebae as opportunistic and non-opportunistic pathogens of humans and animals. International Journal for Parasitology 34: 1001-1027. https://doi.org/10.1016/j.ijpara.2004.06.004
• [4] Łanocha N., Kosik-Bogacka D., Maciejewska A., Sawczuk M., Wilk A., Kuźna-Grygiel W. 2009. The occurrence Acanthamoeba (free living amoeba) in environmental and respiratory samples in Poland. Acta Protozoologica 48: 271-279.
• [5] Lass A., Szostakowska B., Idzińska A., Chomicz L. 2014. The first genotype determination of Acanthamoeba potential threat to human health, isolated from natural water reservoirs in Poland. Parasitology Research 113: 2693-2699. https://dx.doi.org/10.1007/436.1432-1955
• [6] Walochnik J., Obwaller A., Haller-Schober E.M., Aspöck H. 2001. Anti-Acanthamoeba IgG, IgM, and IgA immunoreactivities in correlation to strain pathogenicity. Parasitology Research 87: 651-656. https://doi.org/10.1007/s004360100412
• [7] Schroeder J.M., Booton G.C., Hay J., Niszl I.A., Seal D.V., Markus M.B., Fuerst P.A., Byers T.J. 2001. Use of subgenic 18S ribosomal DNA PCR and sequencing for genus and genotype identification of Acanthamoebae from humans with keratitis and from sewage sludge. Journal of Clinical Microbiology 2: 1903-1911. https://doi.org/10.1128/JCM.39.5.1903-1911.2001
• [8] Brindley N., Matin A., Khan N.A. 2009. Acanthamoeba castellanii: high antibody prevalence in racially and ethnically diverse populations. Experimental Parasitology 121: 254-256. https://doi.org/10.1016/j.exppara.2008.11.009
• [9] Kliescikova, J., Kulda, J., Nohynkova, E. 2011. Stress-induced pseudocyst formation a newly identified mechanism of protection against organic solvents in Acanthamoebae of the T4 genotype. Protist 162: 58-69. https://doi.org/10.1016/j.protis.2010.03.006
• [10] Červa L., Novak K. 1968. Amoebic meningoencephalitis: sixteen fatalities. Science 160: 92 doi:10.1126/science.160.3823.92
• [11] Jones D.B., Visvesvara G.S., Robinson N.M. 1975. Acanthamoeba polyphaga keratitis and Acanthamoeba uveitis associated with fatal meningoencephalitis. Transactions of the Ophthal mological Societies of the United Kingdom 2: 221-232.
• [12] Teknos N., Poulin M.D., Laruentano A.M., Li K.K. 2000. Acanthamoeba rhinosinusitis: characterization, diagnosis, and treatment. American Journal of Rhinology 6: 387-391.
• [13] Visvesvara G.S. 2010. Amebic meningoencephalitides and keratitis: challenges in diagnosis and treatment. Current Opinion in Infectious Diseases 6: 590-594. doi:10.1097/QCO.0b013e32833ed78b
• [14] Berger P., Papazian L., Drancourt M., Lascolat B., Auffray J.P., Raoult D. 2006. Amoeba associated microorganisms and diagnosis of nosocomial pneumonia. Emerging Infectious Diseases 12: 248-255. https://dx.doi.org/10.3201/eid1202.050434
• [15] Santos L.C., Oliveira M.S., Lobo R.D., Higashino H.R., Costa S.F., van der Heijden I.M., Giudice M.C., Silva A.R., Levin A.S. 2009. Acanthamoeba spp. in urine of critically ill patients. Emerging Infectious Diseases 15: 1144-1146. https://dx.doi.org/10.3201/eid1507.081415
• [16] Coulon C., Collignon A., McDonnell G., Thomas V. 2010. Resistance of Acanthamoeba cysts to disinfection treatments used in health care settings. Journal of Clinical Microbiology 48: 2689-2697. doi:10.1128/JCM.00309-10
• [17] Khan N.A. 2015. Acanthamoeba: Biology and Pathogenesis. 2nd ed. Caister Academic Press.
• [18] Nagington J., Watson P.G., Playfair T.J., Mcgill J., Jones B., Steele A.D.M. 1974. Amoebic infection of the eye. The Lancet 304: 1537-1540.
• [19] Visvesvara G.S., Jones D.B., Robinson N.M. 1975. Isolation, identification, and biological characterization of Acanthamoeba polyphaga from a human eye. The American Journal of Tropical Medicine and Hygiene 5: 784-790.
• [20] Wesołowska M., Cisowska A., Myjak P., Marek J., Jurowska-Liput J., Jakubaszko J. 2006. Acanthamoeba keratitis in contact lens wearers in Poland. Advances in Clinical and Experimental Medicine 15: 553-555.
• [21] Lorenzo-Morales J., Martín-Navarro C.M., López-Arencibia A., Arnalich-Montiel F., Piñero J.E., Valladares B. 2013. Acanthamoeba keratitis: an emerging disease gathering importance worldwide? Trends in Parasitology 29: 181-187. https://doi.org/10.1016/j.pt.2013.01.006
• [22] Padzik M., Chomicz L., Szaflik J. P., Chrusikowska A., Perkowski K., Szaflik J. 2014. In vitro effects of selected contact lens care solutions on Acanthamoeba castellanii strains in Poland. Experimental Parasitology 145 (Suppl.): 98-101. https://doi.org/10.1016/j.exppara.2014.06.014
• [23] Risler A., Coupat-Goutaland B., Pélandakis M. 2013. Genotyping and phylogenetic analysis of Acanthamoeba isolates associated with keratitis. Parasitology Research 112: 3807-3816. https://doi.org/10.1007/s00436-013-3572-3
• [24] Chomicz L., Padzik M., Szaflik J.P., Nahorski W.L., Kryczka T., Szaflik J. 2014. Monitoring of in vitro dynamics of Acanthamoeba strains isolated from infected eyes as a useful tool in keratitis management. Experimental Parasitology 145 (Suppl): 73-77. doi:10.1016/j.exppara.2014.06.021
• [25] Lorenzo-Morales J., Khan N.A., Walochnik J. 2015. An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment. Parasite 22: 1-20. doi:10.1051/parasite/2015010
• [26] McDonnell G., Denver Russell A. 1999. Antiseptics and disinfectants: activity, action, and resistance. Clinical Microbiology Reviews 12: 147-179.
• [27] Turner N.A., Russell A.D., Furr J.R., Lloyd D. 2000. Emergence of resistance to biocides during differentiation of Acanthamoeba castellanii. Journal of Antimicrobial Chemotherapy 46: 27-34. https://doi.org/10.1093/jac/46.1.27
• [28] Lloyd D., Turner N.A., Khunkitti W., Hann A.C., Furr J.R., Russell A.D. 2001. Encystation in Acanthamoeba castellanii: development of biocide resistance. Journal of Eukaryotic Microbiology 48: 11-16. doi:10.1111/j.1550-7408.2001.tb00410.x
• [29] Aksozek A., McClellan K., Howard K., Niederkorn J.Y., Alizadeh H. 2002. Resistance of Acanthamoeba castellanii cysts to physical, chemical and radiological conditions. Journal of Parasitology 88: 621-623. https://doi.org/10.1645/0022-3395(2002)088[0621: ROACCT]2.0.CO;2
• [30] Kopańska K., Najda A., Żebrowska J., Chomicz L., Piekarczyk J., Myjak P., Bretner M. 2004. Synthesis and activity of 1H-benzimidazole and 1Hbenzotriazole derivatives as inhibitors of Acanthamoeba castellanii. Bioorganic and Medicinal Chemistry 12: 2617-2624. https://doi.org/10.1016/j.bmc.2004.03.022
• [31] Chomicz L., Conn D.B., Padzik M., Szaflik J.P., Walochnik J., Zawadzki P.J., Pawłowski W., Dybicz M. 2015. Emerging threats for human health in Poland: pathogenic isolates from drug resistant Acanthamoeba keratitis monitored in terms of their in vitro dynamics and temperature adaptability. BioMed Research International: 231285. http://dx.doi.org/10.1155/2015/231285

Identyfikatory

DOI

10.17420/ap6303.102